HEADER OXYGEN TRANSPORT 11-NOV-03 1URV TITLE CRYSTAL STRUCTURE OF CYTOGLOBIN: THE FOURTH GLOBIN TYPE DISCOVERED IN TITLE 2 MAN DISPLAYS HEME HEXA-COORDINATION COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYTOGLOBIN; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: HISTOGLOBIN, HGB, STELLATE CELL ACTIVATION-ASSOCIATED- COMPND 5 PROTEIN, CYGB, STAP; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_TAXID: 9606; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS GLOBIN, CYTOGLOBIN, HISTOGLOBIN, HEME, HEXA-COORDINATION, PROTEIN, KEYWDS 2 OXYGEN TRANSPORT EXPDTA X-RAY DIFFRACTION AUTHOR D.DE SANCTIS,S.DEWILDE,A.PESCE,L.MOENS,P.ASCENZI,T.HANKELN, AUTHOR 2 T.BURMESTER,M.BOLOGNESI REVDAT 4 02-MAY-18 1URV 1 AUTHOR JRNL REMARK REVDAT 3 24-FEB-09 1URV 1 VERSN REVDAT 2 23-DEC-04 1URV 1 SOURCE REVDAT 1 15-DEC-04 1URV 0 JRNL AUTH D.DE SANCTIS,S.DEWILDE,A.PESCE,L.MOENS,P.ASCENZI,T.HANKELN, JRNL AUTH 2 T.BURMESTER,M.BOLOGNESI JRNL TITL CRYSTAL STRUCTURE OF CYTOGLOBIN: THE FOURTH GLOBIN TYPE JRNL TITL 2 DISCOVERED IN MAN DISPLAYS HEME HEXA-COORDINATION. JRNL REF J.MOL.BIOL. V. 336 917 2004 JRNL REFN ISSN 0022-2836 JRNL PMID 15095869 JRNL DOI 10.1016/J.JMB.2003.12.063 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 22020 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.222 REMARK 3 R VALUE (WORKING SET) : 0.219 REMARK 3 FREE R VALUE : 0.265 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1190 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2464 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 112 REMARK 3 SOLVENT ATOMS : 98 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.44 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.13000 REMARK 3 B22 (A**2) : -0.06000 REMARK 3 B33 (A**2) : 0.19000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.220 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.191 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 1URV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-NOV-03. REMARK 100 THE DEPOSITION ID IS D_1290013938. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-AUG-03 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 5.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.934 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 341899 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.500 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 7.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.45 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.03 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 5.00 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.47000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 50.45650 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.21450 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 50.45650 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.47000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.21450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED MUTATION IN CHAIN A, CYS 38 TO SER 38 REMARK 400 ENGINEERED MUTATION IN CHAIN A, CYS 83 TO SER 83 REMARK 400 ENGINEERED MUTATION IN CHAIN B, CYS 38 TO SER 38 REMARK 400 ENGINEERED MUTATION IN CHAIN B, CYS 83 TO SER 83 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLU A 2 REMARK 465 LYS A 3 REMARK 465 VAL A 4 REMARK 465 PRO A 5 REMARK 465 GLY A 6 REMARK 465 GLU A 7 REMARK 465 MET A 8 REMARK 465 GLU A 9 REMARK 465 ILE A 10 REMARK 465 GLU A 11 REMARK 465 ARG A 12 REMARK 465 ARG A 13 REMARK 465 GLU A 14 REMARK 465 ARG A 15 REMARK 465 SER A 16 REMARK 465 GLU A 17 REMARK 465 VAL A 172 REMARK 465 GLN A 173 REMARK 465 GLN A 174 REMARK 465 VAL A 175 REMARK 465 PRO A 176 REMARK 465 ASN A 177 REMARK 465 ALA A 178 REMARK 465 THR A 179 REMARK 465 THR A 180 REMARK 465 PRO A 181 REMARK 465 PRO A 182 REMARK 465 ALA A 183 REMARK 465 THR A 184 REMARK 465 LEU A 185 REMARK 465 PRO A 186 REMARK 465 SER A 187 REMARK 465 SER A 188 REMARK 465 GLY A 189 REMARK 465 PRO A 190 REMARK 465 MET B 1 REMARK 465 GLU B 2 REMARK 465 LYS B 3 REMARK 465 VAL B 4 REMARK 465 PRO B 5 REMARK 465 GLY B 6 REMARK 465 GLU B 7 REMARK 465 MET B 8 REMARK 465 GLU B 9 REMARK 465 ILE B 10 REMARK 465 GLU B 11 REMARK 465 ARG B 12 REMARK 465 ARG B 13 REMARK 465 GLU B 14 REMARK 465 ARG B 15 REMARK 465 SER B 16 REMARK 465 GLU B 17 REMARK 465 VAL B 172 REMARK 465 GLN B 173 REMARK 465 GLN B 174 REMARK 465 VAL B 175 REMARK 465 PRO B 176 REMARK 465 ASN B 177 REMARK 465 ALA B 178 REMARK 465 THR B 179 REMARK 465 THR B 180 REMARK 465 PRO B 181 REMARK 465 PRO B 182 REMARK 465 ALA B 183 REMARK 465 THR B 184 REMARK 465 LEU B 185 REMARK 465 PRO B 186 REMARK 465 SER B 187 REMARK 465 SER B 188 REMARK 465 GLY B 189 REMARK 465 PRO B 190 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 25 CD CE NZ REMARK 480 GLU A 146 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 LYS A 25 CG LYS A 25 CD -0.412 REMARK 500 GLU A 146 CB GLU A 146 CG 0.234 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LYS A 25 CB - CG - CD ANGL. DEV. = 30.6 DEGREES REMARK 500 ASP A 40 CB - CG - OD2 ANGL. DEV. = 5.9 DEGREES REMARK 500 ASP A 68 CB - CG - OD2 ANGL. DEV. = 5.5 DEGREES REMARK 500 ASP A 98 CB - CG - OD2 ANGL. DEV. = 5.9 DEGREES REMARK 500 ASP B 40 CB - CG - OD2 ANGL. DEV. = 6.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 63 24.41 -147.06 REMARK 500 SER A 141 -9.54 -55.00 REMARK 500 SER B 20 162.83 -49.74 REMARK 500 ASN B 37 50.68 -115.89 REMARK 500 ASN B 37 58.92 -115.93 REMARK 500 PHE B 63 28.73 -142.08 REMARK 500 SER B 141 -44.36 143.04 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A1172 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 113 NE2 REMARK 620 2 HEM A1172 NA 100.4 REMARK 620 3 HEM A1172 NB 94.4 91.2 REMARK 620 4 HEM A1172 NC 85.3 174.2 89.1 REMARK 620 5 HEM A1172 ND 89.4 87.8 176.2 91.6 REMARK 620 6 HIS A 81 NE2 170.5 87.2 91.1 87.0 85.2 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM B1172 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 81 NE2 REMARK 620 2 HEM B1172 NA 85.1 REMARK 620 3 HEM B1172 NB 98.1 87.2 REMARK 620 4 HEM B1172 NC 93.5 178.6 92.7 REMARK 620 5 HEM B1172 ND 79.7 91.0 177.3 89.0 REMARK 620 6 HIS B 113 NE2 173.8 90.7 86.3 90.8 95.9 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A1172 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FC6 A1173 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM B1172 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FC6 B1173 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1UMO RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF CYTOGLOBIN: THE FOURTH GLOBIN TYPE REMARK 900 DISCOVERED IN AMN DBREF 1URV A 1 190 UNP Q8WWM9 CYGB_HUMAN 1 190 DBREF 1URV B 1 190 UNP Q8WWM9 CYGB_HUMAN 1 190 SEQADV 1URV SER A 38 UNP Q8WWM9 CYS 38 ENGINEERED MUTATION SEQADV 1URV SER A 83 UNP Q8WWM9 CYS 83 ENGINEERED MUTATION SEQADV 1URV SER B 38 UNP Q8WWM9 CYS 38 ENGINEERED MUTATION SEQADV 1URV SER B 83 UNP Q8WWM9 CYS 83 ENGINEERED MUTATION SEQRES 1 A 190 MET GLU LYS VAL PRO GLY GLU MET GLU ILE GLU ARG ARG SEQRES 2 A 190 GLU ARG SER GLU GLU LEU SER GLU ALA GLU ARG LYS ALA SEQRES 3 A 190 VAL GLN ALA MET TRP ALA ARG LEU TYR ALA ASN SER GLU SEQRES 4 A 190 ASP VAL GLY VAL ALA ILE LEU VAL ARG PHE PHE VAL ASN SEQRES 5 A 190 PHE PRO SER ALA LYS GLN TYR PHE SER GLN PHE LYS HIS SEQRES 6 A 190 MET GLU ASP PRO LEU GLU MET GLU ARG SER PRO GLN LEU SEQRES 7 A 190 ARG LYS HIS ALA SER ARG VAL MET GLY ALA LEU ASN THR SEQRES 8 A 190 VAL VAL GLU ASN LEU HIS ASP PRO ASP LYS VAL SER SER SEQRES 9 A 190 VAL LEU ALA LEU VAL GLY LYS ALA HIS ALA LEU LYS HIS SEQRES 10 A 190 LYS VAL GLU PRO VAL TYR PHE LYS ILE LEU SER GLY VAL SEQRES 11 A 190 ILE LEU GLU VAL VAL ALA GLU GLU PHE ALA SER ASP PHE SEQRES 12 A 190 PRO PRO GLU THR GLN ARG ALA TRP ALA LYS LEU ARG GLY SEQRES 13 A 190 LEU ILE TYR SER HIS VAL THR ALA ALA TYR LYS GLU VAL SEQRES 14 A 190 GLY TRP VAL GLN GLN VAL PRO ASN ALA THR THR PRO PRO SEQRES 15 A 190 ALA THR LEU PRO SER SER GLY PRO SEQRES 1 B 190 MET GLU LYS VAL PRO GLY GLU MET GLU ILE GLU ARG ARG SEQRES 2 B 190 GLU ARG SER GLU GLU LEU SER GLU ALA GLU ARG LYS ALA SEQRES 3 B 190 VAL GLN ALA MET TRP ALA ARG LEU TYR ALA ASN SER GLU SEQRES 4 B 190 ASP VAL GLY VAL ALA ILE LEU VAL ARG PHE PHE VAL ASN SEQRES 5 B 190 PHE PRO SER ALA LYS GLN TYR PHE SER GLN PHE LYS HIS SEQRES 6 B 190 MET GLU ASP PRO LEU GLU MET GLU ARG SER PRO GLN LEU SEQRES 7 B 190 ARG LYS HIS ALA SER ARG VAL MET GLY ALA LEU ASN THR SEQRES 8 B 190 VAL VAL GLU ASN LEU HIS ASP PRO ASP LYS VAL SER SER SEQRES 9 B 190 VAL LEU ALA LEU VAL GLY LYS ALA HIS ALA LEU LYS HIS SEQRES 10 B 190 LYS VAL GLU PRO VAL TYR PHE LYS ILE LEU SER GLY VAL SEQRES 11 B 190 ILE LEU GLU VAL VAL ALA GLU GLU PHE ALA SER ASP PHE SEQRES 12 B 190 PRO PRO GLU THR GLN ARG ALA TRP ALA LYS LEU ARG GLY SEQRES 13 B 190 LEU ILE TYR SER HIS VAL THR ALA ALA TYR LYS GLU VAL SEQRES 14 B 190 GLY TRP VAL GLN GLN VAL PRO ASN ALA THR THR PRO PRO SEQRES 15 B 190 ALA THR LEU PRO SER SER GLY PRO HET HEM A1172 43 HET FC6 A1173 13 HET HEM B1172 43 HET FC6 B1173 13 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM FC6 HEXACYANOFERRATE(3-) HETSYN HEM HEME HETSYN FC6 FERRI(III)HEXACYANIDE FORMUL 3 HEM 2(C34 H32 FE N4 O4) FORMUL 4 FC6 2(C6 FE N6) FORMUL 7 HOH *98(H2 O) HELIX 1 1 SER A 20 ALA A 36 1 17 HELIX 2 2 ASN A 37 PHE A 53 1 17 HELIX 3 3 PRO A 54 PHE A 60 5 7 HELIX 4 4 ASP A 68 SER A 75 1 8 HELIX 5 5 SER A 75 ASN A 95 1 21 HELIX 6 6 ASP A 98 LYS A 116 1 19 HELIX 7 7 PRO A 121 PHE A 139 1 19 HELIX 8 8 ALA A 140 PHE A 143 5 4 HELIX 9 9 PRO A 144 VAL A 169 1 26 HELIX 10 10 SER B 20 ASN B 37 1 18 HELIX 11 11 ASN B 37 PHE B 53 1 17 HELIX 12 12 PHE B 53 GLN B 58 1 6 HELIX 13 13 ASP B 68 SER B 75 1 8 HELIX 14 14 SER B 75 ASN B 95 1 21 HELIX 15 15 ASP B 98 LYS B 116 1 19 HELIX 16 16 PRO B 121 PHE B 139 1 19 HELIX 17 17 PRO B 144 VAL B 169 1 26 LINK NE2 HIS A 113 FE HEM A1172 1555 1555 1.96 LINK FE HEM A1172 NE2 HIS A 81 1555 1555 2.20 LINK FE HEM B1172 NE2AHIS B 81 1555 1555 2.27 LINK FE HEM B1172 NE2 HIS B 113 1555 1555 2.21 SITE 1 AC1 13 TYR A 59 PHE A 60 GLN A 77 HIS A 81 SITE 2 AC1 13 ARG A 84 VAL A 85 ALA A 112 HIS A 113 SITE 3 AC1 13 HIS A 117 VAL A 119 PHE A 124 HOH A2033 SITE 4 AC1 13 HOH A2055 SITE 1 AC2 9 LYS A 125 ARG A 155 GLY A 156 TYR A 159 SITE 2 AC2 9 HOH A2043 HOH A2057 PHE B 53 PRO B 54 SITE 3 AC2 9 SER B 55 SITE 1 AC3 17 GLU A 138 PHE A 139 ALA A 140 SER A 141 SITE 2 AC3 17 HOH A2049 TYR B 59 PHE B 60 GLN B 62 SITE 3 AC3 17 HIS B 81 ARG B 84 ALA B 88 HIS B 113 SITE 4 AC3 17 HIS B 117 VAL B 119 TYR B 123 PHE B 124 SITE 5 AC3 17 LEU B 127 SITE 1 AC4 7 PHE A 53 PRO A 54 SER A 55 LYS B 125 SITE 2 AC4 7 ARG B 155 GLY B 156 TYR B 159 CRYST1 48.940 70.429 100.913 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020433 -0.000001 -0.000001 0.00000 SCALE2 0.000000 0.014199 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009910 0.00000